FloSeal Tubeless Exit Versus Cope Loop Nephrostomy Versus Fascial Stitch Following Percutaneous Nephrolithotripsy
| Status: | Completed |
|---|---|
| Conditions: | Nephrology, Nephrology, Nephrology |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/14/2016 |
| Start Date: | June 2004 |
| End Date: | January 2015 |
Prospective Randomized Trial of Floseal Tubeless Exit vs. Cope Loop Nephrostomy vs. Fascial Stitch Following Percutaneous Nephrolithotripsy
The patient will be asked to participate in a research project designed to determine the
best way to prevent bleeding and promote patient comfort after having kidney stones removed.
Two standard methods for ending the surgery are being compared to a newer method. In one
standard method, the patient will have a tube draining urine from the kidney after the
procedure. This tube may also prevent bleeding from the kidney. In another standard method
the patient will have a tube left internally that drains urine from the kidney to the
bladder and a stitch will be used to close the incision and deeper tissues in the back. In
the third potential option, a tube would be left internally to drain urine from the kidney
to the patient's bladder and the surgical site would be filled with a clot promoting agent
(FloSeal) which is a FDA approved agent specifically formulated to stop bleeding during
surgical procedures.
best way to prevent bleeding and promote patient comfort after having kidney stones removed.
Two standard methods for ending the surgery are being compared to a newer method. In one
standard method, the patient will have a tube draining urine from the kidney after the
procedure. This tube may also prevent bleeding from the kidney. In another standard method
the patient will have a tube left internally that drains urine from the kidney to the
bladder and a stitch will be used to close the incision and deeper tissues in the back. In
the third potential option, a tube would be left internally to drain urine from the kidney
to the patient's bladder and the surgical site would be filled with a clot promoting agent
(FloSeal) which is a FDA approved agent specifically formulated to stop bleeding during
surgical procedures.
Inclusion Criteria:
- The patient has kidney stones that require treatment (tx) with percutaneous stone
removal
- 18 years of age or over
Exclusion Criteria:
- Patient mentally impaired, have a chronic pain syndrome or disorder, or any condition
that might alter the sensation of pain
- Patient taking coumadin
- Pre-existing percutaneous nephrostomy
We found this trial at
1
site
Click here to add this to my saved trials
